Yousif Capital Management LLC Sells 132 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Yousif Capital Management LLC lowered its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 1.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,445 shares of the medical instruments supplier’s stock after selling 132 shares during the period. Yousif Capital Management LLC’s holdings in ICU Medical were worth $1,466,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the stock. Allworth Financial LP lifted its holdings in ICU Medical by 100.0% during the 3rd quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 100 shares in the last quarter. Venturi Wealth Management LLC increased its position in shares of ICU Medical by 1,510.0% during the third quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier’s stock valued at $59,000 after buying an additional 302 shares during the period. Point72 Hong Kong Ltd bought a new stake in shares of ICU Medical during the third quarter valued at about $72,000. Greenleaf Trust purchased a new stake in shares of ICU Medical in the third quarter worth about $207,000. Finally, OLD National Bancorp IN bought a new position in shares of ICU Medical in the third quarter valued at approximately $218,000. 96.10% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on ICUI shares. StockNews.com raised shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, November 20th. KeyCorp upped their price target on shares of ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a report on Wednesday, November 13th. Jefferies Financial Group raised ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price objective for the company in a research note on Wednesday, December 11th. Finally, Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a research report on Wednesday, November 13th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, ICU Medical currently has an average rating of “Moderate Buy” and a consensus target price of $199.67.

ICU Medical Trading Down 0.6 %

Shares of ICU Medical stock opened at $156.94 on Thursday. The company has a 50 day simple moving average of $160.73 and a two-hundred day simple moving average of $164.16. The firm has a market cap of $3.84 billion, a PE ratio of -34.34 and a beta of 0.63. ICU Medical, Inc. has a 1 year low of $93.36 and a 1 year high of $196.26. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03.

Insider Buying and Selling

In other news, CEO Vivek Jain sold 1,373 shares of the company’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total value of $213,474.04. Following the completion of the sale, the chief executive officer now owns 104,593 shares of the company’s stock, valued at approximately $16,262,119.64. This represents a 1.30 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, COO Christian B. Voigtlander sold 1,962 shares of the stock in a transaction on Monday, November 25th. The shares were sold at an average price of $169.08, for a total transaction of $331,734.96. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 17,737 shares of company stock worth $2,879,752. Corporate insiders own 6.70% of the company’s stock.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.